Jonathan Andrus, co-CEO of CRIO, explains how protocol-driven eSource templates and standardized data capture are improving ...

Beyond sharing data, DQS aligns multiple data sources, including sponsors’ clinical trial management system data, public registries, and clinical trial databases, to provide a single, holistic, and ...

A recent study found that up to 40% of trials might be untrustworthy due to flaws in design, improper data collection, and ...

Alps Group Inc (the “Company” or “Alps Group”), the parent company of Alps Life Sciences Inc. (“Alps Holdco”), a fully ...

Researchers at The Hospital for Sick Children (SickKids), working with international collaborators and youth and family ...

In paediatrics, “more trials have been done over the last ten years, but we have struggled with transparency and clarity, and sometimes with the quality because they are not always asking the ...

Dosimetry data from the Phase 3 ECLIPSE substudy demonstrated favorable organ radiation absorbed doses supporting administration of 7.4 GBq for up to six cycles BOSTON, Feb. 26, 2026 (GLOBE NEWSWIRE) ...

Blinded, Sham-Controlled Study Designed to be Executed in Collaboration with Lindus Health to Support Future FDA Submission ...

The first participant has been dosed in Regimen I of the HEALEY ALS Platform Trial evaluating Neurizon Therapeutics’ lead ...

Much uncertainty remains in the evidence base for child and adolescent health. Not only is the quality of clinical trials ...

Total revenues for Q4 2025 were $57.6 million, with Vafseo net product revenues at $6.2 million and Auryxia net product revenues at $48.1 million. Net loss in Q4 2025 was $12.2 million. Cash and cash ...